US 11318205
IRAK degraders and uses thereof
granted A61KA61K31/404A61K31/422
Quick answer
US patent 11318205 (IRAK degraders and uses thereof) held by Kymera Therapeutics, Inc. expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kymera Therapeutics, Inc.
- Grant date
- Tue May 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/404, A61K31/422, A61K31/427, A61K31/4439